Network origin in Nina Kennedy first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London.
31
| Holding Company | Investment Managers | 31 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nina Kennedy via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Cambridge | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member Founder Corporate Officer/Principal | |
Cybele Therapeutics Ltd.
 Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Cybele Therapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 23, 2019 and is headquartered in Reading, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Mestag Therapeutics Ltd.
 Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Financial Conglomerates | Director/Board Member Founder | |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Zarodex Therapeutics Ltd.
 Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Loqus23 Therapeutics Ltd.
 Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer | |
Alchemab Therapeutics Ltd.
 Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Biotechnology | Director/Board Member Founder | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Ervaxx Ltd.
 Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Biotechnology | Director/Board Member Chairman | |
| Enara Bio Ltd. | Biotechnology | Chief Executive Officer Founder | |
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Cellinta Ltd. operates as a biotechnology firm. The company was founded on August 16, 2019 and is headquartered in Reading, the United Kingdom. | Investment Managers | Director/Board Member Director/Board Member | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Founder Founder | |
Endlyz Therapeutics, Inc.
 Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Chief Executive Officer | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Copenhagen | College/University | Doctorate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
| University of Delaware | College/University | Doctorate Degree | |
The Foundry LLC
 The Foundry LLC Investment ManagersFinance The Foundry LLC provides investment services to medical device companies. It includes the inventor partners of business development, product development and prototyping, market analysis and development, human resources and recruitment and intellectual property enterprise. The company was founded by Allan R Will and Henry A. Plain, Jr. in 1998 and is headquartered in Menlo Park, CA. | Investment Managers | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Affera, Inc.
 Affera, Inc. Medical SpecialtiesHealth Technology Affera, Inc. manufactures medical devices for cardiac arrhythmia treatment. The firm develops system to treat heart rhythm disorders. The company was founded by Doron Harlev and is headquartered in Watertown, MA. | Medical Specialties | Director/Board Member | |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Norwich Ventures Management LLC
 Norwich Ventures Management LLC Investment ManagersFinance Norwich Ventures Management LLC (Norwich Ventures) is a venture capital firm founded in 2004 by Aaron Sandoski and Marlin Miller. The firm is headquartered in Wyomissing, Pennsylvania. | Investment Managers | Founder | |
Connective Orthopaedics, Inc.
 Connective Orthopaedics, Inc. Medical SpecialtiesHealth Technology Connective Orthopaedics, Inc. provides surgical and medical instruments. The company is headquartered in Waltham, MA. | Medical Specialties | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree | |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| MASSMEDICA S.A. | Medical Distributors | Director/Board Member | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Director/Board Member | |
| Solspark, Inc. | Private Equity Investor | ||
Podimetrics, Inc.
 Podimetrics, Inc. Medical SpecialtiesHealth Technology Podimetrics, Inc. Develops sensor-enabled mats for prediction and prevention of diabetic foot ulcers. The firm offers Remote Temperature Monitoring System which is a wireless in-home monitoring technology that collects foot temperature scans. The company was founded by Jonathon Bloom, David Linders, Brian Petersen, Jeffery Engler, Kale Dave and Marnix Hollander and is headquartered in Somerville, MA. | Medical Specialties | Director/Board Member | |
De Novo Ventures LLC
 De Novo Ventures LLC Investment ManagersFinance De Novo Ventures LLC (De Novo ventures) is a venture capital firm founded in 2000 by Frederick Dotzler, Richard Ferrari and David Mauney. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Analyst |
Statistics
International
| United States | 29 |
| United Kingdom | 18 |
| Switzerland | 3 |
| Denmark | 3 |
| Poland | 2 |
Sectoral
| Health Technology | 24 |
| Finance | 10 |
| Consumer Services | 9 |
| Commercial Services | 8 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 97 |
| Private Equity Investor | 35 |
| Corporate Officer/Principal | 34 |
| Chairman | 21 |
| Founder | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Kate Bingham | 31 |
| Houman Ashrafian | 22 |
| Ruth McKernan | 16 |
| Allan W. May | 16 |
| Anne Prener | 14 |
| Kevin Pojasek | 14 |
| Hamish Alan Cameron | 14 |
| Graham J. Boulnois | 14 |
| Aaron Sandoski | 12 |
| Brett K. Haumann | 11 |
| Iain Kilty | 8 |
| Ryan Pierce | 8 |
| Jonathan Behr | 8 |
| Christian Billy Jung | 6 |
| Barbara Tate | 6 |
- Stock Market
- Insiders
- Nina Kennedy
- Company connections
